Skip to Main content
General Public
Back
Overview
Sharing health data
Researching and developing new medicines
Sector image
Access to new medicines
Relationship with the NHS
Members of Parliament
Back
Overview
Domestic contribution
Researching and developing new medicines
Healthcare Professionals
Back
Overview
Research and Development
Relationship with the NHS
Engagement with the sector
ABPI Code of Practice and Disclosure UK
Segmentation
Back
Overview
Key driver analysis
Supporters
Neutrals
Unfamiliar
Trusting optimist
Detractors
Covid-19 Response
Back
General Public
Members of Parliament
HCPs
Methodology
Back
Home
Back
UK Pharma Reputation Index
COVID-19 response: General Public
General Public
General Public
Read more about how the pandemic affected public opinion towards pharmaceutical companies operating in the UK
Please select the area…
General Public
COVID-19 response: Members of Parliament
COVID-19 response: HCPs
Last modified:
21 August 2024
Last reviewed:
21 August 2024
